You have read all your free articles, to continue reading subscribe to read the rest of this content.
Xbrane Biopharma has announced that a Marketing Authorization Application (MAA) for biosimilar ranibizumab submitted by its co-development and commercialization partner, STADA Arzneimittel AG, has been validated by the European Medicines Agency (EMA). Submission took place on September 9th and vaAlready a subscriber Login You have read all your free articles,…
UmanDiagnostics has signed a new licensing and supply agreement with global giant Siemens. “Siemens is a world leader in our industry, so this is an extremely important agreement for us,” says Niklas Norgren, CEO of UmanDiagnostics. Acquired by Quanterix This summer UmanDiagnostics was purcAlready a subscriber Login You have read…
Swedish Saromics Biostructures join forces with Swiss Bioversys to fight against multidrug-resistant bacterial infections. The two companies will collaborate in an international project supported by the European initiative Eurostars. Saromics Biostructures and Bioversys will combine technology Already a subscriber Login You have read all your free articles, to continue reading subscribe to…
Alligator Bioscience has signed a research collaboration agreement with Professor Ignacio Melero, MD, PhD, Center for Applied Medical Research (CIMA) and Clínica Universidad de Navarra, Spain, to further investigate the biology of 4-1BB (CD137) as a target in cancer immunotherapy. Alligator hAlready a subscriber Login You have read all your free articles, to…
